How Sponsors Reduce Chaos in Decentralized Trials
89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...
The Complexities of Ophthalmic Drug Development
Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...
Implementing Patient Co-Creation in Clinical Trials
Patient co-creation in clinical research means a shift from thinking about the patient to thinking with the patient. This means that patients are giving...